The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global mRNA Synthesis Service Market Research Report 2025

Global mRNA Synthesis Service Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1951805

No of Pages : 109

Ask Your Query
Synopsis
The global mRNA Synthesis Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for mRNA Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Synthesis Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for mRNA Synthesis Service in Clinical is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of mRNA Synthesis Service include APExBIO, Takeda Pharmaceuticals, Tesla, Thermo Fisher Scientific, VGXI, WACKER Chemie, Siegfried, ST Pharm and Novartis, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for mRNA Synthesis Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Synthesis Service.
Report Scope
The mRNA Synthesis Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Synthesis Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Synthesis Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
APExBIO
Takeda Pharmaceuticals
Tesla
Thermo Fisher Scientific
VGXI
WACKER Chemie
Siegfried
ST Pharm
Novartis
Novo Nordisk
Pfizer
LakePharma
Lion TCR
Lonza
Merck
GlaxoSmithKline
GenePharma
Fareva
Fosun Pharma
GC Pharma
Syneos Health
Bayer
Beijing Tricision Biotherapeutics
Cellerna
Eli Lilly
CMC Pharmaceuticals
Segment by Type
mRNA Vaccine Synthesis
mRNA Drug Synthesis
Segment by Application
Clinical
Research
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Synthesis Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Synthesis Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 mRNA Vaccine Synthesis
1.2.3 mRNA Drug Synthesis
1.3 Market by Application
1.3.1 Global mRNA Synthesis Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical
1.3.3 Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Synthesis Service Market Perspective (2019-2030)
2.2 mRNA Synthesis Service Growth Trends by Region
2.2.1 Global mRNA Synthesis Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Synthesis Service Historic Market Size by Region (2019-2024)
2.2.3 mRNA Synthesis Service Forecasted Market Size by Region (2025-2030)
2.3 mRNA Synthesis Service Market Dynamics
2.3.1 mRNA Synthesis Service Industry Trends
2.3.2 mRNA Synthesis Service Market Drivers
2.3.3 mRNA Synthesis Service Market Challenges
2.3.4 mRNA Synthesis Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Synthesis Service Players by Revenue
3.1.1 Global Top mRNA Synthesis Service Players by Revenue (2019-2024)
3.1.2 Global mRNA Synthesis Service Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Synthesis Service Revenue
3.4 Global mRNA Synthesis Service Market Concentration Ratio
3.4.1 Global mRNA Synthesis Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Synthesis Service Revenue in 2023
3.5 mRNA Synthesis Service Key Players Head office and Area Served
3.6 Key Players mRNA Synthesis Service Product Solution and Service
3.7 Date of Enter into mRNA Synthesis Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Synthesis Service Breakdown Data by Type
4.1 Global mRNA Synthesis Service Historic Market Size by Type (2019-2024)
4.2 Global mRNA Synthesis Service Forecasted Market Size by Type (2025-2030)
5 mRNA Synthesis Service Breakdown Data by Application
5.1 Global mRNA Synthesis Service Historic Market Size by Application (2019-2024)
5.2 Global mRNA Synthesis Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Synthesis Service Market Size (2019-2030)
6.2 North America mRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Synthesis Service Market Size by Country (2019-2024)
6.4 North America mRNA Synthesis Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Synthesis Service Market Size (2019-2030)
7.2 Europe mRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Synthesis Service Market Size by Country (2019-2024)
7.4 Europe mRNA Synthesis Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Synthesis Service Market Size (2019-2030)
8.2 Asia-Pacific mRNA Synthesis Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Synthesis Service Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Synthesis Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Synthesis Service Market Size (2019-2030)
9.2 Latin America mRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Synthesis Service Market Size by Country (2019-2024)
9.4 Latin America mRNA Synthesis Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Synthesis Service Market Size (2019-2030)
10.2 Middle East & Africa mRNA Synthesis Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Synthesis Service Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Synthesis Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 APExBIO
11.1.1 APExBIO Company Detail
11.1.2 APExBIO Business Overview
11.1.3 APExBIO mRNA Synthesis Service Introduction
11.1.4 APExBIO Revenue in mRNA Synthesis Service Business (2019-2024)
11.1.5 APExBIO Recent Development
11.2 Takeda Pharmaceuticals
11.2.1 Takeda Pharmaceuticals Company Detail
11.2.2 Takeda Pharmaceuticals Business Overview
11.2.3 Takeda Pharmaceuticals mRNA Synthesis Service Introduction
11.2.4 Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2019-2024)
11.2.5 Takeda Pharmaceuticals Recent Development
11.3 Tesla
11.3.1 Tesla Company Detail
11.3.2 Tesla Business Overview
11.3.3 Tesla mRNA Synthesis Service Introduction
11.3.4 Tesla Revenue in mRNA Synthesis Service Business (2019-2024)
11.3.5 Tesla Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific mRNA Synthesis Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2019-2024)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 VGXI
11.5.1 VGXI Company Detail
11.5.2 VGXI Business Overview
11.5.3 VGXI mRNA Synthesis Service Introduction
11.5.4 VGXI Revenue in mRNA Synthesis Service Business (2019-2024)
11.5.5 VGXI Recent Development
11.6 WACKER Chemie
11.6.1 WACKER Chemie Company Detail
11.6.2 WACKER Chemie Business Overview
11.6.3 WACKER Chemie mRNA Synthesis Service Introduction
11.6.4 WACKER Chemie Revenue in mRNA Synthesis Service Business (2019-2024)
11.6.5 WACKER Chemie Recent Development
11.7 Siegfried
11.7.1 Siegfried Company Detail
11.7.2 Siegfried Business Overview
11.7.3 Siegfried mRNA Synthesis Service Introduction
11.7.4 Siegfried Revenue in mRNA Synthesis Service Business (2019-2024)
11.7.5 Siegfried Recent Development
11.8 ST Pharm
11.8.1 ST Pharm Company Detail
11.8.2 ST Pharm Business Overview
11.8.3 ST Pharm mRNA Synthesis Service Introduction
11.8.4 ST Pharm Revenue in mRNA Synthesis Service Business (2019-2024)
11.8.5 ST Pharm Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis mRNA Synthesis Service Introduction
11.9.4 Novartis Revenue in mRNA Synthesis Service Business (2019-2024)
11.9.5 Novartis Recent Development
11.10 Novo Nordisk
11.10.1 Novo Nordisk Company Detail
11.10.2 Novo Nordisk Business Overview
11.10.3 Novo Nordisk mRNA Synthesis Service Introduction
11.10.4 Novo Nordisk Revenue in mRNA Synthesis Service Business (2019-2024)
11.10.5 Novo Nordisk Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer mRNA Synthesis Service Introduction
11.11.4 Pfizer Revenue in mRNA Synthesis Service Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 LakePharma
11.12.1 LakePharma Company Detail
11.12.2 LakePharma Business Overview
11.12.3 LakePharma mRNA Synthesis Service Introduction
11.12.4 LakePharma Revenue in mRNA Synthesis Service Business (2019-2024)
11.12.5 LakePharma Recent Development
11.13 Lion TCR
11.13.1 Lion TCR Company Detail
11.13.2 Lion TCR Business Overview
11.13.3 Lion TCR mRNA Synthesis Service Introduction
11.13.4 Lion TCR Revenue in mRNA Synthesis Service Business (2019-2024)
11.13.5 Lion TCR Recent Development
11.14 Lonza
11.14.1 Lonza Company Detail
11.14.2 Lonza Business Overview
11.14.3 Lonza mRNA Synthesis Service Introduction
11.14.4 Lonza Revenue in mRNA Synthesis Service Business (2019-2024)
11.14.5 Lonza Recent Development
11.15 Merck
11.15.1 Merck Company Detail
11.15.2 Merck Business Overview
11.15.3 Merck mRNA Synthesis Service Introduction
11.15.4 Merck Revenue in mRNA Synthesis Service Business (2019-2024)
11.15.5 Merck Recent Development
11.16 GlaxoSmithKline
11.16.1 GlaxoSmithKline Company Detail
11.16.2 GlaxoSmithKline Business Overview
11.16.3 GlaxoSmithKline mRNA Synthesis Service Introduction
11.16.4 GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2019-2024)
11.16.5 GlaxoSmithKline Recent Development
11.17 GenePharma
11.17.1 GenePharma Company Detail
11.17.2 GenePharma Business Overview
11.17.3 GenePharma mRNA Synthesis Service Introduction
11.17.4 GenePharma Revenue in mRNA Synthesis Service Business (2019-2024)
11.17.5 GenePharma Recent Development
11.18 Fareva
11.18.1 Fareva Company Detail
11.18.2 Fareva Business Overview
11.18.3 Fareva mRNA Synthesis Service Introduction
11.18.4 Fareva Revenue in mRNA Synthesis Service Business (2019-2024)
11.18.5 Fareva Recent Development
11.19 Fosun Pharma
11.19.1 Fosun Pharma Company Detail
11.19.2 Fosun Pharma Business Overview
11.19.3 Fosun Pharma mRNA Synthesis Service Introduction
11.19.4 Fosun Pharma Revenue in mRNA Synthesis Service Business (2019-2024)
11.19.5 Fosun Pharma Recent Development
11.20 GC Pharma
11.20.1 GC Pharma Company Detail
11.20.2 GC Pharma Business Overview
11.20.3 GC Pharma mRNA Synthesis Service Introduction
11.20.4 GC Pharma Revenue in mRNA Synthesis Service Business (2019-2024)
11.20.5 GC Pharma Recent Development
11.21 Syneos Health
11.21.1 Syneos Health Company Detail
11.21.2 Syneos Health Business Overview
11.21.3 Syneos Health mRNA Synthesis Service Introduction
11.21.4 Syneos Health Revenue in mRNA Synthesis Service Business (2019-2024)
11.21.5 Syneos Health Recent Development
11.22 Bayer
11.22.1 Bayer Company Detail
11.22.2 Bayer Business Overview
11.22.3 Bayer mRNA Synthesis Service Introduction
11.22.4 Bayer Revenue in mRNA Synthesis Service Business (2019-2024)
11.22.5 Bayer Recent Development
11.23 Beijing Tricision Biotherapeutics
11.23.1 Beijing Tricision Biotherapeutics Company Detail
11.23.2 Beijing Tricision Biotherapeutics Business Overview
11.23.3 Beijing Tricision Biotherapeutics mRNA Synthesis Service Introduction
11.23.4 Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2019-2024)
11.23.5 Beijing Tricision Biotherapeutics Recent Development
11.24 Cellerna
11.24.1 Cellerna Company Detail
11.24.2 Cellerna Business Overview
11.24.3 Cellerna mRNA Synthesis Service Introduction
11.24.4 Cellerna Revenue in mRNA Synthesis Service Business (2019-2024)
11.24.5 Cellerna Recent Development
11.25 Eli Lilly
11.25.1 Eli Lilly Company Detail
11.25.2 Eli Lilly Business Overview
11.25.3 Eli Lilly mRNA Synthesis Service Introduction
11.25.4 Eli Lilly Revenue in mRNA Synthesis Service Business (2019-2024)
11.25.5 Eli Lilly Recent Development
11.26 CMC Pharmaceuticals
11.26.1 CMC Pharmaceuticals Company Detail
11.26.2 CMC Pharmaceuticals Business Overview
11.26.3 CMC Pharmaceuticals mRNA Synthesis Service Introduction
11.26.4 CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2019-2024)
11.26.5 CMC Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
List of Tables
Table 1. Global mRNA Synthesis Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of mRNA Vaccine Synthesis
Table 3. Key Players of mRNA Drug Synthesis
Table 4. Global mRNA Synthesis Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global mRNA Synthesis Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global mRNA Synthesis Service Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global mRNA Synthesis Service Market Share by Region (2019-2024)
Table 8. Global mRNA Synthesis Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global mRNA Synthesis Service Market Share by Region (2025-2030)
Table 10. mRNA Synthesis Service Market Trends
Table 11. mRNA Synthesis Service Market Drivers
Table 12. mRNA Synthesis Service Market Challenges
Table 13. mRNA Synthesis Service Market Restraints
Table 14. Global mRNA Synthesis Service Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global mRNA Synthesis Service Market Share by Players (2019-2024)
Table 16. Global Top mRNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis Service as of 2023)
Table 17. Ranking of Global Top mRNA Synthesis Service Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by mRNA Synthesis Service Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Synthesis Service Product Solution and Service
Table 21. Date of Enter into mRNA Synthesis Service Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Synthesis Service Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global mRNA Synthesis Service Revenue Market Share by Type (2019-2024)
Table 25. Global mRNA Synthesis Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global mRNA Synthesis Service Revenue Market Share by Type (2025-2030)
Table 27. Global mRNA Synthesis Service Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global mRNA Synthesis Service Revenue Market Share by Application (2019-2024)
Table 29. Global mRNA Synthesis Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global mRNA Synthesis Service Revenue Market Share by Application (2025-2030)
Table 31. North America mRNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America mRNA Synthesis Service Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America mRNA Synthesis Service Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe mRNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe mRNA Synthesis Service Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe mRNA Synthesis Service Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific mRNA Synthesis Service Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific mRNA Synthesis Service Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific mRNA Synthesis Service Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America mRNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America mRNA Synthesis Service Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America mRNA Synthesis Service Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa mRNA Synthesis Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa mRNA Synthesis Service Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa mRNA Synthesis Service Market Size by Country (2025-2030) & (US$ Million)
Table 46. APExBIO Company Detail
Table 47. APExBIO Business Overview
Table 48. APExBIO mRNA Synthesis Service Product
Table 49. APExBIO Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 50. APExBIO Recent Development
Table 51. Takeda Pharmaceuticals Company Detail
Table 52. Takeda Pharmaceuticals Business Overview
Table 53. Takeda Pharmaceuticals mRNA Synthesis Service Product
Table 54. Takeda Pharmaceuticals Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 55. Takeda Pharmaceuticals Recent Development
Table 56. Tesla Company Detail
Table 57. Tesla Business Overview
Table 58. Tesla mRNA Synthesis Service Product
Table 59. Tesla Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 60. Tesla Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific mRNA Synthesis Service Product
Table 64. Thermo Fisher Scientific Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. VGXI Company Detail
Table 67. VGXI Business Overview
Table 68. VGXI mRNA Synthesis Service Product
Table 69. VGXI Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 70. VGXI Recent Development
Table 71. WACKER Chemie Company Detail
Table 72. WACKER Chemie Business Overview
Table 73. WACKER Chemie mRNA Synthesis Service Product
Table 74. WACKER Chemie Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 75. WACKER Chemie Recent Development
Table 76. Siegfried Company Detail
Table 77. Siegfried Business Overview
Table 78. Siegfried mRNA Synthesis Service Product
Table 79. Siegfried Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 80. Siegfried Recent Development
Table 81. ST Pharm Company Detail
Table 82. ST Pharm Business Overview
Table 83. ST Pharm mRNA Synthesis Service Product
Table 84. ST Pharm Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 85. ST Pharm Recent Development
Table 86. Novartis Company Detail
Table 87. Novartis Business Overview
Table 88. Novartis mRNA Synthesis Service Product
Table 89. Novartis Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 90. Novartis Recent Development
Table 91. Novo Nordisk Company Detail
Table 92. Novo Nordisk Business Overview
Table 93. Novo Nordisk mRNA Synthesis Service Product
Table 94. Novo Nordisk Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 95. Novo Nordisk Recent Development
Table 96. Pfizer Company Detail
Table 97. Pfizer Business Overview
Table 98. Pfizer mRNA Synthesis Service Product
Table 99. Pfizer Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 100. Pfizer Recent Development
Table 101. LakePharma Company Detail
Table 102. LakePharma Business Overview
Table 103. LakePharma mRNA Synthesis Service Product
Table 104. LakePharma Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 105. LakePharma Recent Development
Table 106. Lion TCR Company Detail
Table 107. Lion TCR Business Overview
Table 108. Lion TCR mRNA Synthesis Service Product
Table 109. Lion TCR Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 110. Lion TCR Recent Development
Table 111. Lonza Company Detail
Table 112. Lonza Business Overview
Table 113. Lonza mRNA Synthesis Service Product
Table 114. Lonza Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 115. Lonza Recent Development
Table 116. Merck Company Detail
Table 117. Merck Business Overview
Table 118. Merck mRNA Synthesis Service Product
Table 119. Merck Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 120. Merck Recent Development
Table 121. GlaxoSmithKline Company Detail
Table 122. GlaxoSmithKline Business Overview
Table 123. GlaxoSmithKline mRNA Synthesis Service Product
Table 124. GlaxoSmithKline Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 125. GlaxoSmithKline Recent Development
Table 126. GenePharma Company Detail
Table 127. GenePharma Business Overview
Table 128. GenePharma mRNA Synthesis Service Product
Table 129. GenePharma Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 130. GenePharma Recent Development
Table 131. Fareva Company Detail
Table 132. Fareva Business Overview
Table 133. Fareva mRNA Synthesis Service Product
Table 134. Fareva Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 135. Fareva Recent Development
Table 136. Fosun Pharma Company Detail
Table 137. Fosun Pharma Business Overview
Table 138. Fosun Pharma mRNA Synthesis Service Product
Table 139. Fosun Pharma Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 140. Fosun Pharma Recent Development
Table 141. GC Pharma Company Detail
Table 142. GC Pharma Business Overview
Table 143. GC Pharma mRNA Synthesis Service Product
Table 144. GC Pharma Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 145. GC Pharma Recent Development
Table 146. Syneos Health Company Detail
Table 147. Syneos Health Business Overview
Table 148. Syneos Health mRNA Synthesis Service Product
Table 149. Syneos Health Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 150. Syneos Health Recent Development
Table 151. Bayer Company Detail
Table 152. Bayer Business Overview
Table 153. Bayer mRNA Synthesis Service Product
Table 154. Bayer Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 155. Bayer Recent Development
Table 156. Beijing Tricision Biotherapeutics Company Detail
Table 157. Beijing Tricision Biotherapeutics Business Overview
Table 158. Beijing Tricision Biotherapeutics mRNA Synthesis Service Product
Table 159. Beijing Tricision Biotherapeutics Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 160. Beijing Tricision Biotherapeutics Recent Development
Table 161. Cellerna Company Detail
Table 162. Cellerna Business Overview
Table 163. Cellerna mRNA Synthesis Service Product
Table 164. Cellerna Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 165. Cellerna Recent Development
Table 166. Eli Lilly Company Detail
Table 167. Eli Lilly Business Overview
Table 168. Eli Lilly mRNA Synthesis Service Product
Table 169. Eli Lilly Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 170. Eli Lilly Recent Development
Table 171. CMC Pharmaceuticals Company Detail
Table 172. CMC Pharmaceuticals Business Overview
Table 173. CMC Pharmaceuticals mRNA Synthesis Service Product
Table 174. CMC Pharmaceuticals Revenue in mRNA Synthesis Service Business (2019-2024) & (US$ Million)
Table 175. CMC Pharmaceuticals Recent Development
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Synthesis Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global mRNA Synthesis Service Market Share by Type: 2023 VS 2030
Figure 3. mRNA Vaccine Synthesis Features
Figure 4. mRNA Drug Synthesis Features
Figure 5. Global mRNA Synthesis Service Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global mRNA Synthesis Service Market Share by Application: 2023 VS 2030
Figure 7. Clinical Case Studies
Figure 8. Research Case Studies
Figure 9. Others Case Studies
Figure 10. mRNA Synthesis Service Report Years Considered
Figure 11. Global mRNA Synthesis Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global mRNA Synthesis Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global mRNA Synthesis Service Market Share by Region: 2023 VS 2030
Figure 14. Global mRNA Synthesis Service Market Share by Players in 2023
Figure 15. Global Top mRNA Synthesis Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Synthesis Service as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by mRNA Synthesis Service Revenue in 2023
Figure 17. North America mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America mRNA Synthesis Service Market Share by Country (2019-2030)
Figure 19. United States mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe mRNA Synthesis Service Market Share by Country (2019-2030)
Figure 23. Germany mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific mRNA Synthesis Service Market Share by Region (2019-2030)
Figure 31. China mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America mRNA Synthesis Service Market Share by Country (2019-2030)
Figure 39. Mexico mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa mRNA Synthesis Service Market Share by Country (2019-2030)
Figure 43. Turkey mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia mRNA Synthesis Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. APExBIO Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 46. Takeda Pharmaceuticals Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 47. Tesla Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 48. Thermo Fisher Scientific Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 49. VGXI Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 50. WACKER Chemie Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 51. Siegfried Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 52. ST Pharm Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 53. Novartis Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 54. Novo Nordisk Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 55. Pfizer Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 56. LakePharma Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 57. Lion TCR Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 58. Lonza Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 59. Merck Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 60. GlaxoSmithKline Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 61. GenePharma Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 62. Fareva Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 63. Fosun Pharma Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 64. GC Pharma Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 65. Syneos Health Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 66. Bayer Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 67. Beijing Tricision Biotherapeutics Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 68. Cellerna Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 69. Eli Lilly Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 70. CMC Pharmaceuticals Revenue Growth Rate in mRNA Synthesis Service Business (2019-2024)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock